Critical Care · 2005 · 18 citations · 0 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceBacteriologyMedical MicrobiologyAntibiotic ResistanceAntimicrobial TherapyBacterial InfectionsBeta-lactam ResistanceClinical BacteriologyHospital Antimicrobial StewardshipAcinetobacter Baumannii InfectionAntibiotic Resistance In Respiratory PathogensAntibiotic-resistant Pathogen ControlDrug-resistant PathogensHealth Care Facility ManagementPneumonia Antibiotic TherapyPseudomonas Aeruginosa ResistanceTreatment Of Bacterial Resistance
The aim of the study was to observe effects of the improvement of the patient's care facility in a medical ICU (MICU) on ICU-acquired pneumonia (IAP), especially caused by drug-resistant bacteria including methicillin-resistant Staphylococcus aureus , third-generation cephalosporin-resistant Acinetobacter baumanii (ISAB), imipenem-intermediate sensitive A. baumanii (IIAB), imipenem-resistant A. baumanii (IRAB), expanded-spectrum beta-lactamase (ESBL), and imipenem-resistant Pseudomonas aeruginosa (IRPA).